Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
XEPTAGEN S.p.A. logo — Targeting unmet needs in personalized oncology

XEPTAGEN S.p.A.

Targeting unmet needs in personalized oncology

Founded 2001 Italy Italy 6 employees Biotechnology, Life Sciences

General Information

Company Name XEPTAGEN S.p.A.
Founded Year 2001
Location Italy Italy +1
Employees 6
Industries Biotechnology, Life Sciences
Social

Get notified when XEPTAGEN S.p.A. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About XEPTAGEN S.p.A.

XEPTAGEN SpA is engaged in the discovery and validation of novel molecular markers in order to produce innovative diagnostic kits for cancer early detection, monitoring, and evaluation of response to therapy. By exploiting the natural immune response to early stage cancer and the proprietary platform technology Combinatorial Proteomic®, XEPTAGEN has discovered predictive, prognostic and early response tumor markers that lead to an earlier and much more accurate detection of developing carcinomas. Our mission includes creating innovative tools that improve the clinical management of cancer patients.

No funding data available for XEPTAGEN S.p.A. yet.

Get notified when XEPTAGEN S.p.A. raises funding

XEPTAGEN S.p.A. Alternatives & Competitors

XEPTAGEN S.p.A. vs
Acuamark Diagnostics, Inc.
Acuamark Diagnostics, Inc. United States

Acuamark Diagnostics develops technology to allow for highly accurate screening of blood to detect c...

Series A
9 employees
Biotechnology, Health Care
XEPTAGEN S.p.A. vs
Advanced fPAT Imaging
Advanced fPAT Imaging

Advanced imaging to identify breast cancer in its earliest stages using JBI-360 technology with Func...

Equity Crowdfunding
Biotechnology, Health Care
XEPTAGEN S.p.A. vs
Epi One
Epi One United States

Taking Cancer Diagnosis to the Next Level

Angel
3 employees
Biotechnology, Health Care

FAQ About XEPTAGEN S.p.A.

Targeting unmet needs in personalized oncology
XEPTAGEN S.p.A. was founded in 2001.
XEPTAGEN S.p.A. is headquartered in Italy.
XEPTAGEN S.p.A. operates in the following industries: Biotechnology, Life Sciences.
XEPTAGEN S.p.A. has approximately 6 employees.
Top alternatives and competitors to XEPTAGEN S.p.A. include Acuamark Diagnostics, Inc., Advanced fPAT Imaging, Epi One, Wren Laboratories, ErleaDx . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
XEPTAGEN S.p.A. and Acuamark Diagnostics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors XEPTAGEN S.p.A. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy